Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Bader S. Alanazi(Cardiff University), Alex Tonks(Cardiff University)
Cited by 61
Related Papers
RUNX3 overexpression inhibits normal human erythroid development
|Scientific Reports|2022|7